Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Joseph H. Saiers"'
Publikováno v:
Journal of Pain and Symptom Management. 21:397-406
The clinical benefit and increased application of opioid rotation has focused attention on efficacy differences between opioids and their respective equianalgesic dose ratios. Understanding the differences between the opioids is critical to understan
Publikováno v:
American Journal of Hospice and Palliative Medicine®. 17:265-268
Autor:
E. David Crawford, Anthony Y. Smith, Brent A. Blumenstein, Michael Wolf, Joseph H. Saiers, Eric H. Kraut, Robert C. Flanigan
Publikováno v:
Investigational New Drugs. 12:147-149
The Southwest Oncology Group (SWOG) studied the response rate and toxicity of merbarone (1,000 mg/m2 IV continuous infusion days 1-5, q 21 days) in patients with advanced metastatic renal cell carcinoma. Among 36 eligible patients, there was one part
Autor:
Stephen M. Loop, Christine A. Gorder, Joseph H. Saiers, Rolf H. Drivdahl, Richard C. Ostenson, Suzanne M. Lewis
Publikováno v:
The Prostate. 26(4)
The effect of [D-Leu 6 ,des-Gly-NH 2 10 , Proethylamide 9 ]-GnRH, leuprolide, was determined for the human primary prostate tumor cell line ALVA-31 by in vitro mitogenic assays. Prostate tumor cell proliferation was inhibited up to 50% by leuprolide.
Autor:
E. David Crawford, Joseph H. Saiers, Brent A. Blumenstein, Charles A. Coltman, Ronald L. Stephens, Saul E. Rivkin
Publikováno v:
The Journal of urology. 150(2 Pt 1)
In a Southwest Oncology Group phase II clinical trial, 68 patients with hormone refractory carcinoma of the prostate were treated with a combination of doxorubicin, mitomycin C and 5-fluorouracil. Of the patients 11 were classified as good risk and 5
Autor:
Richard J Reed, W. J. Stuckey, John N. Bickers, Robert B. Livingston, Joel White, Ronald L. Stephens, Lance K. Heilbrun, Joseph H. Saiers, Joseph D. McCcracken, Michael K. Samson
Publikováno v:
Cancer. 46:2335-2340
From November 1976 to November 1978, the Southwest Oncology Group treated 254 patients with extensive (metastatic) small cell carcinoma of the lung with combination chemotherapy and radiotherapy with and without BCG immunotherapy. Patients receiving
Publikováno v:
Urology. 11:247-250
Multiple agent combination chemotherapy was used to treat 16 patients with Stage D adenocarcinoma of the prostate in relapse. Agents employed were cyclophosphamide (Cytoxan), methotrexate, 5 fluorouracil, vincristine, and prednisone. Results were enc
Publikováno v:
Annals of Internal Medicine. 105:306
Excerpt To the editor: Interferons have been shown to cause regression in several malignancies (1-3). Although the proper role of interferons in the treatment of cancer has yet to be defined, they ...